Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31
Phase 41

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator3
Other Roles2
PI Rate60%

Activity Timeline

Clinical Trials (5)

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Carlo Tondini, MD

Unit of Oncology - Ospedali Riuniti of Bergamo

Related
1 trials

Shared therapeutic areas:

Acute Kidney InjurySolid Tumors

Worked with same sponsors:

Mario Negri Institute for Pharmacological Research
Collaborated on 1 trial
Similarity Score24%

Martino Introna, MD

Cell and Gene Therapy Laboratory "G.Lanzani" Bergamo

Related
1 trials

Shared therapeutic areas:

Acute Kidney InjurySolid Tumors

Worked with same sponsors:

Mario Negri Institute for Pharmacological Research
Collaborated on 1 trial
Similarity Score24%

Giuseppe Remuzzi, MD

Department of Immunology and Clinical Transplantation/Mario Negri Institute for Pharmacological Research and Ospedali Riuniti of Bergamo

Related
1 trials

Shared therapeutic areas:

Acute Kidney InjurySolid Tumors

Worked with same sponsors:

Mario Negri Institute for Pharmacological Research
Collaborated on 1 trial
Similarity Score24%

Alessandro Rambaldi, MD

Unit of Hematology - Ospedali Riuniti of Bergamo

Related
1 trials

Shared therapeutic areas:

Acute Kidney InjurySolid Tumors

Worked with same sponsors:

Mario Negri Institute for Pharmacological Research
Collaborated on 1 trial
Similarity Score24%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score6%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Acute Kidney Injury
Similarity Score6%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score6%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score6%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

Related
8 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score6%

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Solid Tumors
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT01275612Phase 1PrincipalInvestigator

Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers

Acute Kidney InjurySolid Tumors
Withdrawn
NCT00309270Phase 2PrincipalInvestigator

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

Kidney Transplant
Completed
NCT00309283Phase 3PrincipalInvestigator

Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study

Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Completed
NCT00491517Phase 2StudyDirector

Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety

Polycystic Kidney
Completed
NCT00494741Phase 4StudyDirector

MMF vs. AZA for Kidney Transplantation

Kidney Transplant
Completed

All 5 trials loaded